Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Sarcoma Channel is supported with funding from Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ASCO 2017 | What is the future for patients with metastatic sarcoma?

“Breelyn A. Wilky, MD, of the Sylvester Comprehensive Cancer Center, Miami, Fl, talks about her hopes for the future of metastatic sarcoma treatment. She explains that in the future, she hopes that patients with metastatic sarcoma will undergo more than just a pathology review. Whole gene sequencing and immunosignaturing will also be done to generate individualised patient data. Based on the data, a patiens will be able to be given a personalised treatment plan that includes traditional agents like chemotherapy and radiation therapy but also built in with some of the new technology with immunotherapy.
Recorded at the American Society of Oncology (ASCO) 2017 Annual Meeting held in Chicago, IL.”

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.